LISATA THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
LISATA THERAPEUTICS, INC. (LSTA) reported Earnings Per Share, Basic and Diluted of -$0.53 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-02-25
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.29.
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was $0.50.
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.38.
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.47.
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.53.
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.88.
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.67.
- LISATA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2016 was -$4.99.
| Period end | Earnings Per Share, Basic and Diluted 2 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 5 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$0.53 10-K · filed 2021-02-25 | |||||||||
| 2020-09-30 | -$0.29 10-Q · filed 2020-11-05 | -$0.19 10-Q · filed 2020-11-05 | ||||||||
| 2020-06-30 | $0.50 10-Q · filed 2020-08-13 | $0.22 10-Q · filed 2020-08-13 | ||||||||
| 2020-03-31 | -$0.38 10-Q · filed 2020-05-07 | |||||||||
| 2019-12-31 | -$1.88 10-K · filed 2021-02-25 | |||||||||
| 2019-09-30 | -$0.47 10-Q · filed 2020-11-05 | -$0.97 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$1.40 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | -$0.49 10-Q · filed 2020-08-13 | -$0.93 10-Q · filed 2020-08-13 | ||||||||
| 2019-03-31 | -$0.44 10-Q · filed 2020-05-07 | |||||||||
| 2018-12-31 | -$1.67 10-K · filed 2020-03-05 | |||||||||
| 2018-09-30 | -$0.36 10-Q · filed 2019-11-06 | -$0.79 derived: net income ÷ weighted average shares · filed 2019-11-06 | -$1.31 10-Q · filed 2019-11-06 | |||||||
| 2018-06-30 | -$0.42 10-Q · filed 2019-08-08 | -$0.95 10-Q · filed 2019-08-08 | ||||||||
| 2018-03-31 | -$0.52 10-Q · filed 2019-05-09 | |||||||||
| 2017-09-30 | -$0.38 10-Q · filed 2018-11-08 | $3.92 derived: net income ÷ weighted average shares · filed 2018-11-08 | $2.94 10-Q · filed 2018-11-08 | |||||||
| 2017-06-30 | $4.34 10-Q · filed 2018-08-09 | $3.39 10-Q · filed 2018-08-09 | ||||||||
| 2017-03-31 | -$1.12 10-Q · filed 2018-05-10 | |||||||||
| 2016-12-31 | -$4.99 10-K · filed 2017-03-17 | |||||||||
| 2016-09-30 | -$1.09 10-Q · filed 2017-11-09 | -$2.41 derived: net income ÷ weighted average shares · filed 2017-11-09 | -$4.45 10-Q · filed 2017-11-09 | |||||||
| 2016-06-30 | -$1.33 10-Q · filed 2017-08-10 | -$3.39 10-Q · filed 2017-08-10 | ||||||||
| 2016-03-31 | -$2.09 10-Q · filed 2017-05-15 | -$0.21 10-Q · filed 2016-05-05 | ||||||||
| 2015-12-31 | -$0.59 10-K · filed 2016-03-15 | -$16.67 10-K · filed 2017-03-17 | -$1.67 10-K · filed 2016-03-15 | |||||||
| 2015-09-30 | -$2.06 10-Q · filed 2016-11-07 | -$0.21 10-Q · filed 2015-11-05 | -$5.71 derived: net income ÷ weighted average shares · filed 2016-11-07 | -$10.40 10-Q · filed 2016-11-07 | -$1.04 10-Q · filed 2015-11-05 | |||||
| 2015-06-30 | -$3.84 10-Q · filed 2016-08-09 | -$0.38 10-Q · filed 2015-08-06 | -$8.83 10-Q · filed 2016-08-09 | -$0.88 10-Q · filed 2015-08-06 | ||||||
| 2015-03-31 | -$0.51 10-Q · filed 2016-05-05 | |||||||||
| 2014-12-31 | -$0.32 10-K · filed 2016-03-15 | -$1.68 10-K · filed 2016-03-15 | ||||||||
| 2014-09-30 | -$0.48 10-K · filed 2016-03-15 | -$0.17 10-Q · filed 2014-10-30 | -$0.89 derived: net income ÷ weighted average shares · filed 2015-11-05 | -$1.37 10-Q · filed 2015-11-05 | ||||||
| 2014-06-30 | -$0.07 10-Q · filed 2014-08-07 | -$0.40 10-K · filed 2016-03-15 | -$0.88 10-Q · filed 2015-08-06 | |||||||
| 2014-03-31 | -$0.49 10-K · filed 2016-03-15 | |||||||||
| 2013-12-31 | -$0.47 10-K · filed 2015-03-02 | -$1.90 10-K · filed 2016-03-15 | ||||||||
| 2013-09-30 | -$0.45 10-K · filed 2015-03-02 | -$0.91 derived: net income ÷ weighted average shares · filed 2014-10-30 | -$1.43 10-Q · filed 2014-10-30 | |||||||
| 2013-06-30 | -$0.46 10-K · filed 2015-03-02 | -$0.99 10-Q · filed 2014-08-07 | ||||||||
| 2013-03-31 | -$0.53 10-K · filed 2015-03-02 | -$0.05 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | -$4.00 10-K · filed 2015-03-02 | -$0.40 10-K · filed 2013-03-11 | ||||||||
| 2012-09-30 | -$0.64 10-Q · filed 2013-11-07 | -$0.06 10-Q · filed 2012-11-13 | -$3.01 10-Q · filed 2013-11-07 | -$0.30 10-Q · filed 2012-11-13 | ||||||
| 2012-06-30 | -$1.53 10-Q · filed 2013-08-08 | -$0.15 10-Q · filed 2012-08-14 | -$2.44 10-Q · filed 2013-08-08 | -$0.24 10-Q · filed 2012-08-14 | ||||||
| 2012-03-31 | -$0.08 10-Q · filed 2013-05-09 | |||||||||
| 2011-12-31 | -$0.54 10-K · filed 2013-03-11 | |||||||||
| 2011-09-30 | -$0.08 10-Q · filed 2012-11-13 | -$0.35 10-Q · filed 2012-11-13 | ||||||||
| 2011-06-30 | -$0.13 10-Q · filed 2012-08-14 | -$0.27 10-Q · filed 2012-08-14 | ||||||||
| 2011-03-31 | -$0.14 10-Q · filed 2012-05-11 | |||||||||
| 2010-12-31 | -$0.46 8-K · filed 2012-08-15 | |||||||||
| 2010-09-30 | -$0.13 10-Q · filed 2011-11-10 | -$0.36 10-Q · filed 2011-11-10 | ||||||||
| 2010-06-30 | -$0.11 10-Q · filed 2011-08-12 | -$0.23 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |